Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.35 |
| ▸ | NPY4R | P50391 | 2/20 | 0.34 |
| ▸ | NPY1R | P25929 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PLG | P00747 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7439764 | 0.99 | EPHX2 (0.36) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7441948 | 0.88 | EPHX2 (0.44) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7443379 | 0.87 | NPY4R (0.43) | ITGB3ITGA2BEPHX2NPY4RNPY1R | |
| SCHEMBL9439808 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7442799 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7445683 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7438925 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7445001 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7442006 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL7442250 | 0.87 | EPHX2 (0.46) | SMN1; SMN2ITGB3ITGA2BEPHX2NPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | claimed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | claimed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | claimed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | claimed |
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | disclosed |